Javascript must be enabled to continue!
Overview of the EUROfusion Tokamak Exploitation programme in support of ITER and DEMO
View through CrossRef
Abstract
Within the 9th European Framework programme, since 2021 EUROfusion is operating five tokamaks under the auspices of a single Task Force called ‘Tokamak Exploitation’. The goal is to benefit from the complementary capabilities of each machine in a coordinated way and help in developing a scientific output scalable to future largre machines. The programme of this Task Force ensures that ASDEX Upgrade, MAST-U, TCV, WEST and JET (since 2022) work together to achieve the objectives of Missions 1 and 2 of the EUROfusion Roadmap: i) demonstrate plasma scenarios that increase the success margin of ITER and satisfy the requirements of DEMO and, ii) demonstrate an integrated approach that can handle the large power leaving ITER and DEMO plasmas. The Tokamak Exploitation task force has therefore organized experiments on these two missions with the goal to strengthen the physics and operational basis for the ITER baseline scenario and for exploiting the recent plasma exhaust enhancements in all four devices (PEX: Plasma EXhaust) for exploring the solution for handling heat and particle exhaust in ITER and develop the conceptual solutions for DEMO. The ITER Baseline scenario has been developed in a similar way in ASDEX Upgrade, TCV and JET. Key risks for ITER such as disruptions and run-aways have been also investigated in TCV, ASDEX Upgrade and JET. Experiments have explored successfully different divertor configurations (standard, super-X, snowflakes) in MAST-U and TCV and studied tungsten melting in WEST and ASDEX Upgrade. The input from the smaller devices to JET has also been proven successful to set-up novel control schemes on disruption avoidance and detachment.
IOP Publishing
E. Joffrin
M. Wischmeier
M. Baruzzo
A. Hakola
A. Kappatou
D. Keeling
B. Labit
E. Tsitrone
N. Vianello
D. Abate
J. Adamek
M. Agostini
C. Albert
F.C.P. Albert Devasagayam
S. Aleiferis
E. Alessi
J. Alhage
S. Allan
J. Allcock
M. Alonzo
G. Anastasiou
E. Andersson Sunden
C. Angioni
Y. Anquetin
L. Appel
G.M. Apruzzese
M. Ariola
C. Arnas
J.F. Artaud
W. Arter
O. Asztalos
L. Aucone
M.H. Aumeunier
F. Auriemma
J. Ayllon
E. Aymerich
A. Baciero
F. Bagnato
L. Bähner
F. Bairaktaris
P. Balázs
L. Balbinot
I. Balboa
M. Balden
A. Balestri
M. Baquero Ruiz
T. Barberis
C. Barcellona
O. Bardsley
M. Baruzzo
S. Benkadda
T. Bensadon
E. Bernard
M. Bernert
H. Betar
R. Bianchetti Morales
J. Bielecki
R. Bilato
P. Bilkova
W. Bin
G. Birkenmeier
R. Bisson
P. Blanchard
A. Bleasdale
V. Bobkov
A. Boboc
A. Bock
K. Bogar
P. Bohm
T. Bolzonella
F. Bombarda
N. Bonanomi
L. Boncagni
D. Bonfiglio
R. Bonifetto
M. Bonotto
D. Borodin
I. Borodkina
T.O.S.J. Bosman
C. Bourdelle
C. Bowman
S. Brezinsek
D. Brida
F. Brochard
R. Brunet
D. Brunetti
V. Bruno
R. Buchholz
J. Buermans
H. Bufferand
P. Buratti
A. Burckhart
J. Cai
R. Calado
J. Caloud
S. Cancelli
F. Cani
B. Cannas
M. Cappelli
S. Carcangiu
A. Cardinali
S. Carli
D. Carnevale
M. Carole
M. Carpita
D. Carralero
F. Caruggi
I.S. Carvalho
I. Casiraghi
A. Casolari
F.J. Casson
C. Castaldo
A. Cathey
F. Causa
J. Cavalier
M. Cavedon
J. Cazabonne
M. Cecconello
L. Ceelen
A. Celora
J. Cerovsky
C.D. Challis
R. Chandra
A. Chankin
B. Chapman
H. Chen
M. Chernyshova
A.G. Chiariello
P. Chmielewski
A. Chomiczewska
C. Cianfarani
G. Ciraolo
J. Citrin
F. Clairet
S. Coda
R. Coelho
J.W. Coenen
I.H. Coffey
C. Colandrea
L. Colas
S. Conroy
C. Contre
N.J. Conway
L. Cordaro
Y. Corre
D. Costa
S. Costea
D. Coster
X. Courtois
C. Cowley
T. Craciunescu
G. Croci
A.M. Croitoru
K. Crombe
D.J. Cruz Zabala
G. Cseh
T. Czarski
A. Da Ros
A. Dal Molin
M. Dalla Rosa
Y. Damizia
O. D’Arcangelo
P. David
M. De Angeli
E. De la Cal
E. De La Luna
G. De Tommasi
J. Decker
R. Dejarnac
D. Del Sarto
G. Derks
C. Desgranges
P. Devynck
S. Di Genova
L.E. di Grazia
A. Di Siena
M. Dicorato
M. Diez
M. Dimitrova
T. Dittmar
L. Dittrich
J.J. Domínguez Palacios Durán
P. Donnel
D. Douai
S. Dowson
S. Doyle
M. Dreval
P. Drews
L. Dubus
R. Dumont
D. Dunai
M. Dunne
A. Durif
F. Durodie
G. Durr Legoupil Nicoud
B. Duval
R. Dux
T. Eich
A. Ekedahl
S. Elmore
G. Ericsson
J. Eriksson
B. Eriksson
F. Eriksson
S. Ertmer
A. Escarguel
B. Esposito
T. Estrada
E. Fable
M. Faitsch
N. Fakhrayi Mofrad
A. Fanni
T. Farley
M. Farník
N. Fedorczak
F. Felici
X. Feng
J. Ferreira
D. Ferreira
N. Ferron
O. Fevrier
O. Ficker
A.R. Field
A. Figueiredo
N. Fil
D. Fiorucci
M. Firdaouss
R. Fischer
M. Fitzgerald
M. Flebbe
M. Fontana
J. Fontdecaba Climent
A. Frank
E. Fransson
L. Frassinetti
D. Frigione
S. Futatani
R. Futtersack
S. Gabriellini
D. Gadariya
D. Galassi
K. Galazka
J. Galdon
S. Galeani
D. Gallart
A. Gallo
C. Galperti
M. Gambrioli
S. Garavaglia
J. Garcia
M. Garcia Munoz
J. Gardarein
L. Garzotti
J. Gaspar
R. Gatto
P. Gaudio
M. Gelfusa
J. Gerardin
S.N. Gerasimov
R. Gerru Miguelanez
G. Gervasini
Z. Ghani
F.M. Ghezzi
G. Ghillardi
L. Giannone
S. Gibson
L. Gil
A. Gillgren
E. Giovannozzi
C. Giroud
G. Giruzzi
T. Gleiter
M. Gobbin
V. Goloborodko
A. González Ganzábal
T. Goodman
V. Gopakumar
G. Gorini
T. Görler
S. Gorno
G. Granucci
D. Greenhouse
G. Grenfell
M. Griener
W. Gromelski
M. Groth
O. Grover
M. Gruca
A. Gude
C. Guillemaut
R. Guirlet
J. Gunn
T. Gyergyek
L. Hagg
A. Hakola
J. Hall
C.J. Ham
M. Hamed
T. Happel
G. Harrer
J. Harrison
D. Harting
N.C. Hawkes
P. Heinrich
S. Henderson
P. Hennequin
R. Henriques
S. Heuraux
J. Hidalgo Salaverri
J. Hillairet
J.C. Hillesheim
A. Hjalmarsson
A. Ho
J. Hobirk
E. Hodille
M. Hölzl
M. Hoppe
J. Horacek
N. Horsten
L. Horvath
M. Houry
K. Hromasova
J. Huang
Z. Huang
A. Huber
E. Huett
P. Huynh
A. Iantchenko
M. Imrisek
P. Innocente
C. Ionita Schrittwieser
H. Isliker
P. Ivanova
I. Ivanova Stanik
M. Jablczynska
S. Jachmich
A.S. Jacobsen
P. Jacquet
A. Jansen van Vuuren
A. Jardin
H. Järleblad
A. Järvinen
F. Jaulmes
T. Jensen
I. Jepu
S. Jessica
E. Joffrin
T. Johnson
A. Juven
J. Kalis
A. Kappatou
J. Karhunen
R. Karimov
A.N. Karpushov
S. Kasilov
Y. Kazakov
P.V. Kazantzidis
D. Keeling
W. Kernbichler
HT. Kim
D.B. King
V.G. Kiptily
A. Kirjasuo
K.K. Kirov
A. Kirschner
A. Kit
T. Kiviniemi
F. Kjær
E. Klinkby
A. Knieps
U. Knoche
M. Kochan
F. Köchl
G. Kocsis
J.T.W. Koenders
L. Kogan
Y. Kolesnichenko
Y. Kominis
M. Komm
M. Kong
B. Kool
S.B. Korsholm
D. Kos
M. Koubiti
J. Kovacic
Y. Kovtun
E. Kowalska Strzeciwilk
K. Koziol
M. Kozulia
A. Krämer Flecken
A. Kreter
K. Krieger
U. Kruezi
O. Krutkin
O. Kudlacek
U. Kumar
H. Kumpulainen
M.H. Kushoro
R. Kwiatkowski
M. La Matina
B. Labit
M. Lacquaniti
L. Laguardia
P. Lainer
P. Lang
M. Larsen
E. Laszynska
K.D. Lawson
A. Lazaros
E. Lazzaro
M.Y.K. Lee
S. Leerink
M. Lehnen
M. Lennholm
E. Lerche
Y. Liang
A. Lier
J. Likonen
O. Linder
B. Lipschultz
A. Listopad
X. Litaudon
E. Litherland Smith
D. Liuzza
T. Loarer
P.J. Lomas
J. Lombardo
N. Lonigro
R. Lorenzini
C. Lowry
T. Luda di Cortemiglia
A. Ludvig Osipov
T. Lunt
V. Lutsenko
E. Macusova
R. Mäenpää
P. Maget
C.F. Maggi
J. Mailloux
S. Makarov
K. Malinowski
P. Manas
A. Mancini
D. Mancini
P. Mantica
M. Mantsinen
J. Manyer
M. Maraschek
G. Marceca
G. Marcer
C. Marchetto
S. Marchioni
A. Mariani
M. Marin
M. Markl
T. Markovic
D. Marocco
S. Marsden
L. Martellucci
P. Martin
C. Martin
F. Martinelli
L. Martinelli
J.R. Martin Solis
R. Martone
M. Maslov
R. Masocco
M. Mattei
G.F. Matthews
D. Matveev
E. Matveeva
M.L. Mayoral
D. Mazon
S. Mazzi
C. Mazzotta
G. McArdle
R. McDermott
K. McKay
A.G. Meigs
C. Meineri
A. Mele
V. Menkovski
S. Menmuir
A. Merle
H. Meyer
K. Mikszuta Michalik
D. Milanesio
F. Militello
A. Milocco
I.G. Miron
J. Mitchell
R. Mitteau
V. Mitterauer
J. Mlynar
V. Moiseenko
P. Molna
F. Mombelli
C. Monti
A. Montisci
J. Morales
P. Moreau
J.M. Moret
A. Moro
D. Moulton
P. Mulholland
M. Muraglia
A. Murari
A. Muraro
P. Muscente
D. Mykytchuk
F. Nabais
Y. Nakeva
F. Napoli
E. Nardon
M.F. Nave
R.D. Nem
A. Nielsen
S.K. Nielsen
M. Nocente
R. Nouailletas
S. Nowak
H. Nyström
R. Ochoukov
N. Offeddu
S. Olasz
C. Olde
F. Oliva
D. Oliveira
H.J.C. Oliver
P. Ollus
J. Ongena
F.P. Orsitto
N. Osborne
R. Otin
P. Oyola Dominguez
D.I. Palade
S. Palomba
O. Pan
N. Panadero
E. Panontin
A. Papadopoulos
P. Papagiannis
G. Papp
V.V. Parail
C. Pardanaud
J. Parisi
A. Parrott
K. Paschalidis
M. Passoni
F. Pastore
A. Patel
B. Patel
A. Pau
G. Pautasso
R. Pavlichenko
E. Pawelec
B. Pegourie
G. Pelka
E. Peluso
A. Perek
E. Perelli Cippo
C. Perez Von Thun
P. Petersson
G. Petravich
Y. Peysson
V. Piergotti
L. Pigatto
C. Piron
L. Piron
A. Pironti
F. Pisano
U. Plank
B. Ploeckl
V. Plyusnin
A. Podolnik
Y. Poels
G. Pokol
J. Poley
G. Por
M. Poradzinski
F. Porcelli
L. Porte
C. Possieri
A. Poulsen
I. Predebon
G. Pucella
M. Pueschel
P. Puglia
O. Putignano
T. Pütterich
V. Quadri
A. Quercia
M. Rabinski
L. Radovanovic
R. Ragona
H. Raj
M. Rasinski
J. Rasmussen
G. Ratta
S. Ratynskaia
R. Rayaprolu
M. Rebai
A. Redl
D. Rees
D. Refy
M. Reich
H. Reimerdes
B.C.G. Reman
O. Renders
C. Reux
D. Ricci
M. Richou
S. Rienacker
D. Rigamonti
F. Rigollet
F.G. Rimini
D. Ripamonti
N. Rispoli
N. Rivals
J.F. Rivero Rodriguez
C. Roach
G. Rocchi
S. Rode
P. Rodrigues
J. Romazanov
C.F. Romero Madrid
J. Rosato
R. Rossi
G. Rubino
J. Rueda Rueda
J. Ruiz Ruiz
P. Ryan
D. Ryan
S. Saarelma
R. Sabot
M. Salewski
A. Salmi
L. Sanchis
A. Sand
J. Santos
K. Särkimäki
M. Sassano
O. Sauter
G. Schettini
S. Schmuck
P. Schneider
N. Schoonheere
R. Schramm
R. Schrittwieser
C. Schuster
N. Schwarz
F. Sciortino
M. Scotto D’Abusco
S. Scully
A. Selce
L. Senni
M. Senstius
G. Sergienko
S.E. Sharapov
R. Sharma
A. Shaw
U. Sheikh
G. Sias
B. Sieglin
S.A. Silburn
C. Silva
A. Silva
D. Silvagni
B. Simmendefeldt Schmidt
L. Simons
J. Simpson
L. Singh
S. Sipilä
Y. Siusko
S. Smith
A. Snicker
E.R. Solano
V. Solokha
M. Sos
C. Sozzi
F. Spineanu
G. Spizzo
M. Spolaore
L. Spolladore
C. Srinivasan
A. Stagni
Z. Stancar
G. Stankunas
J. Stober
P. Strand
C.I. Stuart
F. Subba
G.Y. Sun
H.J. Sun
W. Suttrop
J. Svoboda
T. Szepesi
G. Szepesi
B. Tal
T. Tala
P. Tamain
G. Tardini
M. Tardocchi
D. Taylor
G. Telesca
A. Tenaglia
A. Terra
D. Terranova
D. Testa
C. Theiler
E. Tholerus
B. Thomas
E. Thoren
A. Thornton
A. Thrysoe
Q. TICHIT
W. Tierens
A. Titarenko
P. Tolias
E. Tomasina
M. Tomes
E. Tonello
A. Tookey
M. Toscano Jiménez
C. Tsironis
E. Tsitrone
E. Tsitrone
C. Tsui
A. Tykhyy
M. Ugoletti
M. Usoltseva
D.F. Valcarcel
A. Valentini
M. Valisa
M. Vallar
M. Valovic
SI. Valvis
M. van Berkel
D. Van Eester
S. Van Mulders
M. van Rossem
R. Vann
B. Vanovac
J. Varela Rodriguez
J. Varje
S. Vartanian
M. Vecsei
L. Velarde Gallardo
M. Veranda
T. Verdier
G. Verdoolaege
K. Verhaegh
L. Vermare
G. Verona Rinati
N. Vianello
J. Vicente
E. Viezzer
L. Vignitchouk
F. Villone
B. Vincent
P. Vincenzi
M.O. Vlad
G. Vogel
I. Voitsekhovitch
I. Voldiner
P. Vondracek
N.M.T. VU
T. Vuoriheimo
C. Wade
E. Wang
T. Wauters
M. Weiland
H. Weisen
N. Wendler
D. Weston
A. Widdowson
S. Wiesen
M. Wiesenberger
T. Wijkamp
M. Willensdorfer
T. Wilson
M. Wischmeier
A. Wojenski
C. Wuethrich
I. Wyss
L. Xiang
S. Xu
D. Yadykin
Y. Yakovenko
H. Yang
V. Yanovskiy
R. Yi
B. Zaar
G. Zadvitskiy
L. Zakharov
P. Zanca
D. Zarzoso
Y. Zayachuk
J. Zebrowski
M. Zerbini
P. Zestanakis
C. F. B. Zimmermann
M. Zlobinski
A. Zohar
V.K. Zotta
X. Zou
M. Zuin
M. Zurita
I. Zychor
Title: Overview of the EUROfusion Tokamak Exploitation programme in support of ITER and DEMO
Description:
Abstract
Within the 9th European Framework programme, since 2021 EUROfusion is operating five tokamaks under the auspices of a single Task Force called ‘Tokamak Exploitation’.
The goal is to benefit from the complementary capabilities of each machine in a coordinated way and help in developing a scientific output scalable to future largre machines.
The programme of this Task Force ensures that ASDEX Upgrade, MAST-U, TCV, WEST and JET (since 2022) work together to achieve the objectives of Missions 1 and 2 of the EUROfusion Roadmap: i) demonstrate plasma scenarios that increase the success margin of ITER and satisfy the requirements of DEMO and, ii) demonstrate an integrated approach that can handle the large power leaving ITER and DEMO plasmas.
The Tokamak Exploitation task force has therefore organized experiments on these two missions with the goal to strengthen the physics and operational basis for the ITER baseline scenario and for exploiting the recent plasma exhaust enhancements in all four devices (PEX: Plasma EXhaust) for exploring the solution for handling heat and particle exhaust in ITER and develop the conceptual solutions for DEMO.
The ITER Baseline scenario has been developed in a similar way in ASDEX Upgrade, TCV and JET.
Key risks for ITER such as disruptions and run-aways have been also investigated in TCV, ASDEX Upgrade and JET.
Experiments have explored successfully different divertor configurations (standard, super-X, snowflakes) in MAST-U and TCV and studied tungsten melting in WEST and ASDEX Upgrade.
The input from the smaller devices to JET has also been proven successful to set-up novel control schemes on disruption avoidance and detachment.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Results from the last DD and DT JET campaigns in the framework of the EUROfusion Tokamak Exploitation Work Package activity
Results from the last DD and DT JET campaigns in the framework of the EUROfusion Tokamak Exploitation Work Package activity
Abstract
JET, the only tokamak capable of operating with deuterium–tritium (D–T) fuel (since TFTR was shutdown in 1999), has provided essenti...
Overview of T and D–T results in JET with ITER-like wall
Overview of T and D–T results in JET with ITER-like wall
Abstract
In 2021 JET exploited its unique capabilities to operate with T and D–T fuel with an ITER-like Be/W wall (JET-ILW). This second majo...
Simulateur numérique de décharge de Tokamak
Simulateur numérique de décharge de Tokamak
Cette thèse s'inscrit dans le contexte de la recherche sur la fusion nucléaire par confinement magnétique d'un plasma dans un tokamak. Elle a pour objectif de développer un simulat...
Overview of physics studies on ASDEX Upgrade
Overview of physics studies on ASDEX Upgrade
Abstract
The ASDEX Upgrade (AUG) programme, jointly run with the EUROfusion MST1 task force, continues to significantly enhance the physics base of ITER and DEMO. He...

